Ligand · P9I
P9I · 1-[1-(pyridin-2-yl)indolizin-3-yl]ethan-1-one
P9I, 1-[1-(pyridin-2-yl)indolizin-3-yl]ethan-1-one (C15 H13 N2 O +1, 237.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and…
- Component
- P9I
- Formula
- C15 H13 N2 O +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
P9I in 2 structures; the first of them:
- 4A9I · N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one · P9I A1185 · binds TRP97, PRO98, PHE99, GLN101, VAL103, LEU108, LEU110, TYR113 and 3 more
- 4A9I · N-terminal bromodomain of human BRD2 with 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one · P9I A1185 · binds TRP97, PRO98, PHE99, GLN101, VAL103, LEU108, LEU110, TYR113 and 3 more
Residues it binds most
LEU 6, GLN 6, TYR 6, ASN 6, CYS 6, ILE 6, PHE 6, PRO 6, TRP 6, VAL 6 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.